Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia.

Tack J, Masclee A, Heading R, Berstad A, Piessevaux H, Popiela T, Vandenberghe A, Kato H.

Neurogastroenterol Motil. 2009 Mar;21(3):272-80. doi: 10.1111/j.1365-2982.2009.01261.x.


The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.

Grant A, Wileman S, Ramsay C, Bojke L, Epstein D, Sculpher M, Macran S, Kilonzo M, Vale L, Francis J, Mowat A, Krukowski Z, Heading R, Thursz M, Russell I, Campbell M; REFLUX Trial Group..

Health Technol Assess. 2008 Sep;12(31):1-181, iii-iv.


Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal.

Davies NM, GrinyĆ³ J, Heading R, Maes B, Meier-Kriesche HU, Oellerich M.

Nephrol Dial Transplant. 2007 Sep;22(9):2440-8. Epub 2007 Jun 8. Review.


Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome--a European perspective.

Heading R, Bardhan K, Hollerbach S, Lanas A, Fisher G.

Aliment Pharmacol Ther. 2006 Jul 15;24(2):207-36. Review.


Mycophenolate sodium does not reduce the incidence of GI adverse events compared with mycophenolate mofetil.

Meier-Kriesche HU, Davies NM, GrinyĆ³ J, Heading R, Mamelok R, Wijngaard P, Oellerich M, Maes B.

Am J Transplant. 2005 May;5(5):1164; author reply 1165-6. No abstract available.


Review article: sleep and its relationship to gastro-oesophageal reflux.

Orr WC, Heading R, Johnson LF, Kryger M.

Aliment Pharmacol Ther. 2004 Dec;20 Suppl 9:39-46. Review.

Supplemental Content

Loading ...
Support Center